Back to feed

Why Synopsys Lagged Cadence and Why It May Be Cheap

Since June 2022 both EDA leaders have trailed SOXX, and Synopsys fell further under Ansys debt and share dilution. The duopoly structure, the Multiphysics Fusion wave and a cleaner IP lineup support renewed growth. The open question is execution: can management deliver promised double digit growth and stronger cash generation.

Imported to Nodesdaily: (UTC+03:00)
Watch on YouTube — roRYuPnXGPA
Reading options

Device speech is unavailable in this browser.

Concept lens

Choose a technical term in this view to read its general definition, teaching example and use in the article.

No terms from our glossary were found in this view. The glossary does not cover every term yet.

Start with an uncomfortable chart: since June 2022 both Synopsys and Cadence have trailed the SOXX basket by a wide margin, and the gap between the purple and orange lines kept widening. They moved together early on, then Cadence pulled ahead over the last two years, yet a broad chip basket still did better. That restraint shows why diversification sometimes disappoints on purpose.

The core is chip design software plus licensed building blocks, growing near high single digits while research budgets compound steadily and the EDA duopoly captures a durable share. Subscription revenue, near total retention and painful switching costs keep cash flow predictable. I compared that picture with the duopoly review published on Arvy, which stresses loyal customers and recurring revenue across cycles.

Product power after the Ansys combination

One year after the Ansys combination, joint products are finally shipping; the first Multiphysics Fusion wave from 17 June 2026 merges timing signoff with physics checks in one flow. Cisco, MediaTek, NVIDIA and Samsung Foundry report runtimes up to three times faster and closure loops up to ten times quicker. I checked that outcome against the launch notice hosted on news.synopsys.com and the shift from overdesign toward co-design looks credible.

The second leg is verification helpers based on machine intelligence, with autonomous checking agents rolling out in stages through 2027. Management expects a revenue effect starting next year and ties mid teens growth to this wave plus stronger EDA demand. I read that timetable together with the third quarter results posted on investor.synopsys.com and the plan looks internally consistent.

The clearest cleanup step was the disposal of processor blocks, as Synopsys agreed to transfer its ARC lineup to GlobalFoundries for 450 million dollars. The package spans ARC-V RISC-V cores, classic ARC, VPX-DSP, NPX NPU units, MetaWare tools and the ASIP Designer suite. I matched that list against the MIPS press notice describing the same product set, and the focus on higher value customization work makes sense.

Why the processor block sale makes sense

The buyer logic reads even better, because the foundry had already absorbed MIPS in August 2025 and now gathers both architectures under one roof. The target is affordable custom silicon for cars, factory gear, airspace defenders, medical devices and edge robotics. I found support for that reading in the GF MIPS analysis published on eetimes.com, which frames an accessible platform against costly bespoke design shops.

Third quarter numbers point to renewed momentum, with fiscal 2026 third quarter revenue at 2.477 billion dollars against 1.74 billion a year earlier. GAAP earnings reached 2.84 dollars per share and adjusted earnings 3.91 dollars, led by design automation near 2 billion dollars. Design IP near 470 million dollars returned to yearly growth at roughly twenty percent of sales, and I confirmed that split against the third quarter results carried on investor.synopsys.com.

The tense part is the balance sheet, with net debt above 6 billion dollars including near term paper while Cadence carries only about 1 billion dollars. Share count grew from merger consideration plus research spending and restructuring, GAAP profit sagged for a stretch and free cash flow per share stayed flat. I weighed that worry against the equity analysis published on Barchart, which flags debt load and slower organic expansion after Ansys.

Valuation and the prove it phase

The six point list is tidy: Ansys debt and dilution, lower Intel concentration, the Cadence Intel alignment, heavier research outlays, IP licensing wobbles and multiple compression. Intel slipped from a low teens share toward below ten percent while its current chief once led Cadence. I evaluated that context alongside the multi year DTCO framework in the 8 June 2026 Intel 14A cooperation note issued by Cadence.

The final reverse DCF step simplifies the debate, because a price near 415 dollars with a ten percent discount and five percent terminal pace implies only nine percent growth across ten years. Yet the 30 September 2026 investor day guides fiscal 2027 toward about fifteen percent growth to 11.15 billion dollars with buybacks up to half of free cash flow . I read that target together with the long term model release distributed over prnewswire, including the near term 1 billion dollar repurchase intent.

Visualization: nodesdaily AI

Key moments

  1. Lagging SOXX
  2. EDA and IP supply chain
  3. Ansys fusion and agents
  4. ARC sale to GlobalFoundries
  5. Revenue and margins
  6. 6B net debt load
  7. Dilution and flat cash
  8. Six reasons for weakness
  9. Reverse DCF near 415
  10. Prove it thesis

AI commentary

"I read this story as punishment and promise from the same source, heavy merger debt alongside genuinely strong engineering products. I keep a calm skeptical tone and follow the logic behind each number."

AI assessment

The product case is solid, since design subscriptions, Ansys physics checks and agent assisted closure raise engineering output and lift switching costs. The earlier IP volatility looks cleaned up, and the design automation trend near double digits can carry the mix. So a mid teens revenue path looks plausible on the top line.

Risk sits in leverage and customer mix, because heavy debt raises interest strain while Intel softness and Cadence rivalry may slow margin repair. Unless share count is worked down, per share growth stays on paper and the multiple stays capped. I balance that view with the cautious market notes associated with Barchart coverage of dilution and leverage.

Valuation looks balanced, after a slide from above thirty times forward cash flow toward the mid twenties, while the reverse calculation prices only high single digit expansion. If management hits the 11.15 billion dollar band for 2027 and the streamlined lineup around MIPS assets lifts margins, the current quote offers a patient entry. That frame should be read with the prnewswire investor day release and the Synopsys long term targets.

The verdict needs proof, since technology is ready and customer cases are live, but debt must fall and per share cash output must climb again. Watching the Cadence 14A push and the Arvy duopoly work helps track the competitive balance. I weigh this set together with the RISC-V platform notes published on eetimes.com and favor a broad, patient portfolio stance.

Sources

9 links; no other published story cites them. Stories sharing a link do not confirm each other; a source's origin is not inferred from how often it is cited.

synopsys · cadence · eda · ansys · risc-v · valuation

Follow the topic

Before this story

A short reading order from earlier stories linked to this event by an editor.

Evidence and sources

Review permitted source passages, versions and origins.

KAYNAKLARLA OKU

Bu haberi açalım.

Hesap kontrol ediliyor…